BIOAFFINITY TECHNOLOGIES INC's ticker is and the CUSIP is 09076W117. A total of 6 filers reported holding BIOAFFINITY TECHNOLOGIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,612 | -82.2% | 204,082 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $104,694 | +71.0% | 204,082 | -0.0% | 0.00% | +100.0% |
| Q1 2023 | $61,225 | -28.6% | 204,083 | +0.0% | 0.00% | 0.0% |
| Q4 2022 | $85,714 | +19.0% | 204,082 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $72,000 | – | 204,082 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Citadel Advisors | 25,718 | $2,348 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 10,525 | $961 | 0.00% |
| CLEAR STREET LLC | 25,400 | $2 | 0.00% |
| Warberg Asset Management LLC | 22,926 | $2,091 | 0.00% |
| ARMISTICE CAPITAL, LLC | 204,082 | $18,612 | 0.00% |